These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 20533956

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Rates and reasons for discontinuation of triptans and opioids in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.
    Holland S, Fanning KM, Serrano D, Buse DC, Reed ML, Lipton RB.
    J Neurol Sci; 2013 Mar 15; 326(1-2):10-7. PubMed ID: 23394974
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Allodynia Is Associated With Initial and Sustained Response to Acute Migraine Treatment: Results from the American Migraine Prevalence and Prevention Study.
    Lipton RB, Munjal S, Buse DC, Bennett A, Fanning KM, Burstein R, Reed ML.
    Headache; 2017 Jul 15; 57(7):1026-1040. PubMed ID: 28603893
    [Abstract] [Full Text] [Related]

  • 7. Predictors of adherence to triptans: factors of sustained vs lapsed users.
    Cady RK, Maizels M, Reeves DL, Levinson DM, Evans JK.
    Headache; 2009 Mar 15; 49(3):386-94. PubMed ID: 19220501
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.
    Buse D, Manack A, Serrano D, Reed M, Varon S, Turkel C, Lipton R.
    Headache; 2012 Jan 15; 52(1):3-17. PubMed ID: 22106869
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB, Munjal S, Buse DC, Fanning KM, Bennett A, Reed ML.
    Headache; 2016 Nov 15; 56(10):1635-1648. PubMed ID: 27731896
    [Abstract] [Full Text] [Related]

  • 14. Patterns of use and health expenses associated with triptans among adults with migraines.
    Wu J, Noxon V, Lu ZK.
    Clin J Pain; 2015 Aug 15; 31(8):673-9. PubMed ID: 25185875
    [Abstract] [Full Text] [Related]

  • 15. Triptans: low utilization and high turnover in the general population.
    Panconesi A, Pavone E, Franchini M, Mennuti N, Bartolozzi M, Guidi L, Banfi R.
    Cephalalgia; 2010 May 15; 30(5):576-81. PubMed ID: 19732070
    [Abstract] [Full Text] [Related]

  • 16. Examination of unmet treatment needs among persons with episodic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB, Buse DC, Serrano D, Holland S, Reed ML.
    Headache; 2013 Sep 15; 53(8):1300-11. PubMed ID: 23879870
    [Abstract] [Full Text] [Related]

  • 17. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC, Loder EW, Gorman JA, Stewart WF, Reed ML, Fanning KM, Serrano D, Lipton RB.
    Headache; 2013 Sep 15; 53(8):1278-99. PubMed ID: 23808666
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.